Replimune Group, Inc. (REPL) has a consensus analyst rating of Buy, based on 15 analysts covering the stock. Of those, 12 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for REPL is $13.75, representing a +605.1% upside from the current price of $1.95. Price targets range from a low of $11.00 to a high of $18.00.